Improving outcomes with bivalirudin in primary percutaneous coronary intervention

被引：0
|
作者：
Stone, Gregg W. [1 ,2 ]
机构：
[1] Columbia Univ, Med Ctr, New York Presbyterian Hosp, New York, NY USA
[2] Cardiovasc Res Fdn, New York, NY USA
来源：
EUROPEAN HEART JOURNAL | 2014年 / 35卷 / 34期
关键词：
ELEVATION MYOCARDIAL-INFARCTION; GLYCOPROTEIN IIB/IIIA INHIBITOR; STENT THROMBOSIS; CLOPIDOGREL PRETREATMENT; HEPARIN MONOTHERAPY; CLINICAL-OUTCOMES; PRIMARY PCI; ABCIXIMAB; THERAPY; METAANALYSIS;
D O I：
10.1093/eurheartj/ehu227
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
[No abstract available]
引用
收藏
页码：2269 / 2272
页数：4
相关论文
共 50 条
  • [31] Angiographic and clinical outcomes of bivalirudin versus heparin inpatients with acute coronary syndrome undergoing percutaneous coronary intervention
    Matar, Fadi
    Donoghue, Colleen
    Rossi, Peter
    Vandormael, Michel
    T Sullebarger, John
    Kerensky, Richard
    Jauch, Werner
    Gloer, Kathy
    Ebra, George
    CANADIAN JOURNAL OF CARDIOLOGY, 2006, 22 (13) : 1139 - 1145
  • [32] Percutaneous coronary intervention outcomes and the impact of pharmacologic selection: Glycoprotein IIbIIIa inhibitors versus bivalirudin
    Jennings, HR
    Poe, KL
    Carrico, JM
    Miller, EC
    Blake, RA
    Sartini, JC
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2005, 45 (03) : 37A - 37A
  • [33] Bivalirudin for primary percutaneous coronary intervention in acute myocardial infarction: the HORIZONS-AMI trial
    Capranzano, Piera
    Dangas, George
    EXPERT REVIEW OF CARDIOVASCULAR THERAPY, 2012, 10 (04) : 411 - 422
  • [34] BIVALIRUDIN VERSUS UNFRACTIONATED HEPARIN MONOTHERAPY IN PERCUTANEOUS CORONARY INTERVENTION: A COMPARISON OF ACUTE ADVERSE OUTCOMES
    Meraj, Perwaiz M.
    Doshi, Rajkumar
    Patel, Amitkumar
    George, Bhavitha
    Kaur, Lakhbir
    Mozawalla, Fatima
    Bhiuya, Tanzim
    Jauhar, Rajiv
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2017, 69 (11) : 268 - 268
  • [35] Bivalirudin Use During Percutaneous Coronary Intervention Improves Clinical and Economic Outcomes in Diabetic Women
    Galbraith, Erin M.
    Mehran, Roxana
    Devireddy, Chandan
    Liberman, Henry A.
    Manoukian, Steven V.
    Voeltz, Michele D.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2011, 58 (20) : B112 - B112
  • [36] Safety and In-Hospital Outcomes of Bivalirudin Use in Dialysis Patients Undergoing Percutaneous Coronary Intervention
    Delhaye, Cedric
    Maluenda, Gabriel
    Wakabayashi, Kohei
    Ben-Dor, Itsik
    Collins, Sara D.
    Syed, Asmir I.
    Gonzalez, Manuel A.
    Gaglia, Michael A.
    Torguson, Rebecca
    Xue, Zhenyi
    Suddath, William O.
    Satler, Lowell F.
    Kent, Kenneth M.
    Lindsay, Joseph
    Pichard, Augusto D.
    Waksman, Ron
    AMERICAN JOURNAL OF CARDIOLOGY, 2010, 105 (03): : 297 - 301
  • [37] Heparin versus Bivalirudin in patients undergoing Percutaneous Coronary Intervention
    Rehmani, Ahmed
    Judkins, Chris
    Lee, Edmund
    Nguyen, Michael
    Whelan, Alan
    Schultz, Carl
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 64 (11) : B135 - B135
  • [38] Use of Prolonged Bivalirudin Infusions Following Percutaneous Coronary Intervention
    Moser, Lynette R.
    Nemerovski, Carrie W.
    Good, Kelley L.
    CARDIOVASCULAR DRUGS AND THERAPY, 2011, 25 (03) : 267 - 276
  • [39] Safety and Efficacy of Bivalirudin for Percutaneous Coronary Intervention with Rotational Atherectomy
    Delhaye, Cedric
    Wakabayashi, Kohei
    Maluenda, Gabriel
    Ben-Dor, Itsik
    Torguson, Rebecca
    Xue, Zhenyi
    Suddath, William O.
    Satler, Lowell F.
    Pichard, Augusto D.
    Kent, Kenneth M.
    Lindsay, Joseph
    Waksman, Ron
    JOURNAL OF INTERVENTIONAL CARDIOLOGY, 2010, 23 (03) : 223 - 229
  • [40] Heparin, bivalirudin, and reduction of complications during percutaneous coronary intervention
    Nappi, J
    PHARMACOTHERAPY, 2002, 22 (06): : 89S - 89S
12345